Latest Articles
It takes women seven years to be diagnosed with endometriosis. That could soon change - MSN
It takes women seven years to be diagnosed with endometriosis. That could soon change MSN
Published: Dec. 30, 2024, 12:36 a.m.
It takes women seven years to be diagnosed with endometriosis. That could soon change - 9News
It takes women seven years to be diagnosed with endometriosis. That could soon change 9News
Published: Dec. 30, 2024, 12:23 a.m.
Proteomics International Laboratories Ltd (ASX:PIQ) Breakthrough Results for Endometriosis Diagnostic Blood Test - ABN Newswire
Proteomics International Laboratories Ltd (ASX:PIQ) Breakthrough Results for Endometriosis Diagnostic Blood Test ABN Newswire
Published: Dec. 29, 2024, 10:22 p.m.
Proteomics International’s PromarkerEndo Set to Revolutionize Endometriosis Diagnosis - TipRanks
Proteomics International’s PromarkerEndo Set to Revolutionize Endometriosis Diagnosis TipRanks
Published: Dec. 29, 2024, 9:48 p.m.
Endo treatment now listed on PBS - Bellarine Times
Endo treatment now listed on PBS Bellarine Times
Published: Dec. 29, 2024, 5:03 p.m.
Endo treatment now listed on PBS - Geelong Times
Endo treatment now listed on PBS Geelong Times
Published: Dec. 29, 2024, 5:03 p.m.
Endometriosis and me: I hope young women today know they should shout louder than I did - The Irish Times
Endometriosis and me: I hope young women today know they should shout louder than I did The Irish Times
Published: Dec. 29, 2024, 6:01 a.m.
Endometriosis treatment - Press TV
Endometriosis treatment Press TV
Published: Dec. 28, 2024, 3 p.m.
Endometriosis Treatment - Press TV
Endometriosis Treatment Press TV
Published: Dec. 28, 2024, 2:39 p.m.
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced or recurrent endometrial cancer in Japan - springermedicine.com
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced …
Published: Dec. 28, 2024, 12:47 p.m.
Link copied to clipboard!